Yi Kong

Currently her research interests include genetically engineered exosomes drug delivery system, network pharmacology of Chinese medicine, and precision medication prediction models. As a principal investigator, she has got funding from Natural Science Foundation of Guangdong Province, department of Education of Guangdong Province and Traditional Chinese Medicine Bureau of Guangdong Province. During the research period, she has published 10 papers and also filed 1 patent. In 2021, she was selected into the Guangdong Provincial High-level Talents Review Expert Database. She serves as a standing member of the First Clinical Therapy Precision Medicine Expert Committee of the Guangdong Pharmaceutical Association, the secretary of the Youth Expert Group of the Pharmacovigilance Alliance of the Guangdong Pharmacological Association. She is the member of the first and second sessions of Evidence-Based Pharmacy of the Guangdong Pharmaceutical Association, member of the First Expert Committee of Drug Evaluation and Clinical Scientific Research of Guangdong Pharmaceutical Association, and member of China Medical Care International Exchange Promotion Association. Taught the courses of “Case Analysis of Clinical Pharmacy” and “Infectious Diseases” (English).